Medicine and Dentistry
Lupus Nephritis
100%
Biopsy
91%
Glomerulonephritis
90%
Vasculitis
79%
Immunoglobulin A Nephropathy
78%
Renal Biopsy
77%
ANCA Associated Vasculitis
72%
Disease
64%
Proteinuria
54%
Complement Component C4d
50%
Neutrophil Cytoplasmic Antibody
47%
Glomerulopathy
47%
Immunosuppressive Treatment
47%
Pathologist
42%
Nephropathy
41%
Renal Pathology
39%
Systemic Lupus Erythematosus
37%
Kidney Transplantation
36%
Transplantation
35%
Diagnosis
35%
End Stage Renal Disease
34%
Granulomatosis with Polyangiitis
32%
Renal Failure
30%
Rheumatic Disease
30%
Kidney Graft
27%
Nephritic Syndrome
27%
IgA Vasculitis
26%
Autoantibodies
25%
Idiopathic Pulmonary Fibrosis
24%
Focal Segmental Glomerulosclerosis
24%
Kidney Function
23%
Glucocorticoid
23%
Electron Microscopy
23%
Diabetic Nephropathy
22%
Microscopy
22%
Injury
22%
Rituximab
21%
Antiphospholipid Antibody
21%
Microangiopathy
20%
Recurrent Disease
20%
Calcineurin Inhibitor
19%
Kidney Allograft
19%
Glomerulus
18%
Systematic Review
18%
Pediatrics
17%
Microscopic Polyangiitis
17%
Glomerular Filtration Rate
17%
Creatinine
16%
Nephrology
15%
Minimal Change Disease
14%
Keyphrases
Antineutrophil Cytoplasmic Antibody-associated Vasculitis
38%
Lupus Nephritis
35%
IgA Nephropathy (IgAN)
34%
Proteinuria
33%
ANCA-associated Glomerulonephritis
30%
Systemic Lupus Erythematosus
28%
Kidney
26%
Granulomatosis with Polyangiitis
22%
ANCA-associated Vasculitis
22%
Light Microscopy
21%
Glomerular Disease
20%
Glomerular Lesions
20%
Consensus Definition
20%
Electron Microscopy
20%
Kidney Transplantation
20%
Renal Pathology
17%
Risk Score
17%
Dialysis
16%
Clinical Trials
16%
Clinical Outcomes
15%
Kidney Graft Survival
15%
End-stage Kidney Disease
15%
Complete Renal Response
15%
Prediction Tool
15%
ANCA Renal Risk Score
14%
Vasculitis
14%
Clinical Practice
14%
Validation Studies
13%
Classification Criteria
13%
Imlifidase
13%
Histological Classification
13%
EULAR Recommendations
12%
Immunosuppression
12%
Therapeutic Approaches
12%
Antineutrophil Cytoplasmic Antibody
12%
Remission
12%
Rituximab
12%
Renal Outcome
11%
Mixed Classes
11%
Patient Survival
11%
C4d Staining
11%
Confidence Interval
10%
Placebo
10%
Classical Complement Activation
10%
Diabetic Nephropathy
10%
Surrogate Marker
10%
CD163+ Macrophages
10%
Individualized Prediction
10%
Recurrent FSGS
10%
Anti-CD40 Antibody
10%
Immunology and Microbiology
Glomerulonephritis
47%
Kidney Transplantation
42%
Vasculitis
36%
Allotransplantation
34%
Complement Activation
32%
Kidney Function
31%
Complement Component C4d
30%
IgA Nephropathy
30%
Systemic Lupus Erythematosus
30%
Autoantibodies
29%
Transplant Procedure
20%
ANCA Associated Vasculitis
20%
Rheumatic Disease
20%
Acute Graft Rejection
20%
Monospecific Antibody
20%
Immunosuppression
17%
Cyclophosphamide
17%
Neutrophil Cytoplasmic Antibody
13%
Nephritis
13%
Lupus Erythematosus
13%
Imlifidase
13%
Tacrolimus
12%
Chemokine
11%
Macrophage
11%
Immunosuppressive Drug
10%
Fibrogenesis
10%
Mannan-Binding Lectin
10%
Microchimerism
10%
Epidermal Growth Factor
10%
Azathioprine
10%
Methylprednisolone
10%
Transforming Growth Factor Beta
10%
CD163
10%
High Risk Population
10%
Pancreas
10%
Artificial Intelligence
10%
Antiphospholipid Syndrome
10%
Goblet Cell
10%
Human Leukocyte Antigen
10%
Reperfusion
10%
Phospholipid Antibody
10%
Mesenchymal Stem Cell
10%
Squamous Cell
10%
Immunosuppressive Therapy
10%
Anti-Glomerular Basement Membrane Antibody
10%
Immune Complex Deposition
10%
Rituximab
10%
Blood Plasma
8%
Creatinine Blood Level
8%
Placenta
8%
